Newly Approved Drug Therapies (474): Lamictal Chewable Dispersible Tablets, GlaxoWellcome

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Lamictal Chewable Dispersible Tablets

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoWellcome
Approval Status: Approved August 1998
Treatment for: Epilepsy

General Information

Lamictal tablets are used for the treatment of Lennox-Gastaut syndrome seizures of patients with severe forms of epilepsy.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]